CoChat

The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index; 43 of the 53 sources its claims cite were checked for support.

A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues

Open access

Published version of a preprint

Abstract

Although cellular senescence drives multiple age-related co-morbidities through the senescence-associated secretory phenotype, in vivo senescent cell identification remains challenging. Here, we generate a gene set (SenMayo) and validate its enrichment in bone biopsies from two aged human cohorts. We further demonstrate reductions in SenMayo in bone following genetic clearance of senescent cells in mice and in adipose tissue from humans following pharmacological senescent cell clearance. We next use SenMayo to identify senescent hematopoietic or mesenchymal cells at the single cell level from human and murine bone marrow/bone scRNA-seq data. Thus, SenMayo identifies senescent cells across tissues and species with high fidelity. Using this senescence panel, we are able to characterize senescent cells at the single cell level and identify key intercellular signaling pathways. SenMayo also represents a potentially clinically applicable panel for monitoring senescent cell burden with aging and other conditions as well as in studies of senolytic drugs.

Overview

CoChat Summary

TL;DR

The paper introduces SenMayo, a 125-gene senescence/SASP panel, and validates its enrichment with aging and reduction after senescent cell clearance across human and mouse bulk and single-cell datasets. SenMayo identifies senescent cells across tissues and species and predicts senescence-associated intercellular signaling pathways.

Key findings

  • SenMayo was generated from 15 studies after screening 1,656 studies and comprises 125 genes, predominantly SASP factors (n = 83), plus transmembrane (n = 20) and intracellular (n = 22) proteins. It was significantly enriched in aged human bone biopsies (p = 0.002 for Cohort A; p = 0.003 for Cohort B) and aged mouse brain regions (p = 0.005, p = 0.001, p < 0.001), whereas the prior R-HSA-2559582 gene set did not reach significance (p = 0.157, p = 0.117, p = 0.192).
  • SenMayo decreased after senescent cell clearance: in old p16-INK-ATTAC mice treated with AP20187, and in human subcutaneous adipose tissue after dasatinib plus quercetin treatment (p = 0.002). Mif mRNA was increased in bones from old versus young mice and significantly reduced after genetic clearance of senescent cells.
  • SenMayo consistently outperformed six additional senescence/SASP gene sets based on normalized enrichment scores and p values across the mouse and human models tested.
  • In scRNA-seq, SenMayo identified SASP cells in human bone marrow (68,478 hematopoietic cells from 20 donors aged 24–84 years; top 10% enrichment yielded 6,850 SASP cells, predominantly monocytic) and in murine bone/bone marrow mesenchymal cells (35,368 cells; 3,537 SASP cells; 21% of osteolineage cells, including 24% OLC1 and 18% OLC2). MIF and PECAM1 pathways were among the most enriched intercellular communication pathways.

Methods

  • SenMayo was built by literature search combining genes reported as enriched in senescent and/or SASP-secreting cells and experimentally verified in human or mouse cells; GSEA used default settings with 1,000 permutations, and network analysis used Cytoscape 3.8.2 with iRegulon.
  • Human bulk RNA-seq included two cohorts of young versus postmenopausal women (Cohort A: young n = 19, 30.3 ± 5.4 years; postmenopausal n = 19, 73.1 ± 6.6 years; Cohort B: young n = 15, 30.9 ± 4.0 years; postmenopausal n = 15, 68.7 ± 4.8 years) and a phase I pilot of 9 diabetic kidney disease patients (7 male, 2 female, 68.7 ± 3.1 years) given dasatinib plus quercetin, with adipose biopsies before and 11 days after treatment.
  • Mouse experiments used old (20 months) female INK-ATTAC mice injected with vehicle or AP20187 (10 mg/kg) twice weekly for 4 months and sacrificed at 24 months, with young (6-month) controls; RT-qPCR measured Mif. scRNA-seq analyses used Seurat v3.0, Louvain clustering at resolution 1.4 yielding 40 clusters, Monocle pseudotime, and CellChat.

Limitations

  • Stated: CDKN2A/p16Ink4a is expressed at low levels even in senescent cells and may not be reliably detected in scRNA-seq; some canonical senescence markers, including CDKN2A/p16Ink4a, did not show the predicted increase with aging due to comparatively low expression. The authors propose co-expression analysis with JUN (human) or Dkk1 (mouse) to address this.
  • Stated: the human dasatinib plus quercetin study was an open-label Phase 1 pilot, proof-of-concept study with an interim analysis, and SenMayo was part of an exploratory analysis.
  • Evident: the human senolytic validation sample was small (9 diabetic kidney disease patients) and limited to subcutaneous adipose tissue; scRNA-seq SASP cells were defined by selecting the top 10% of cells with highest SenMayo expression, a threshold-dependent definition, and the analyses rely on previously published datasets.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-022-32552-1

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Development and validation of the SenMayo gene set. a Human samples from Cohort A (bone and bone marrow biopsies) and cohort B (highly enriched osteocyte fractions) were used for transcriptome-wide RNA-seq analyses; b Making use of TRRUST analyses30, we found several inflammation- and stress-associated genes, including SIRT1 and NFKB1, to be upregulated in the elderly women; p values were adjusted according to Benjamini–Hochberg. c In both gene sets, CDKN1A/P21Cip1 and several SASP markers such as CCL2 and IL6 showed consistent upregulation with aging, while CDKN2A/p16Ink4a (due to comparatively low expression) did not change significantly. Two-sided unpaired t-tests except for CCL2, where a Kolmogorov–Smirnov test was used (cohort A: CDKN2A: p = 0.0834; CDKN1A: p < 0.0001; CCL2: p = 0.0034; IL6: p = 0.6391; cohort B: CDKN2A: p = 0.1658, CDKN1A: p < 0.0001; CCL2: p < 0.0001, IL6: p = 0.0017). d The commonly used senescence/SASP gene set (R-HSA-2559582) failed to predict the aging process in either human cohort. Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested; e The SenMayo gene set includes growth factors, transmembrane receptors, and cytokines/chemokines that are highly influenced by other members of the gene set. The circle size depicts groupwise interactions, arrows point the direction of these interactions. f SenMayo encodes a dense network of nine different protein classes within a strong interaction network. The size of each circle represents the connectivity with other members of the gene set, grey lines represent interactions92; g Genes included in the SenMayo gene set were significantly enriched with aging in both human cohorts. Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested Cohort A: n = 38 (19 young, 19 old, all ♀), Cohort B: n = 30 (15 young, 15 old, all ♀). **p < 0.01, ****p < 0.0001. Fig. 1a was designed using Biorender.com. Depicted are mean ± SEM. Source data are provided as a Source Data file.
Fig. 1 Development and validation of the SenMayo gene set. a Human samples from Cohort A (bone and bone marrow biopsies) and cohort B (highly enriched osteocyte fractions) were used for transcriptome-wide RNA-seq analyses; b Making use of TRRUST analyses30, we found several inflammation- and stress-associated genes, including SIRT1 and NFKB1, to be upregulated in the elderly women; p values were adjusted according to Benjamini–Hochberg. c In both gene sets, CDKN1A/P21Cip1 and several SASP markers such as CCL2 and IL6 showed consistent upregulation with aging, while CDKN2A/p16Ink4a (due to comparatively low expression) did not change significantly. Two-sided unpaired t-tests except for CCL2, where a Kolmogorov–Smirnov test was used (cohort A: CDKN2A: p = 0.0834; CDKN1A: p < 0.0001; CCL2: p = 0.0034; IL6: p = 0.6391; cohort B: CDKN2A: p = 0.1658, CDKN1A: p < 0.0001; CCL2: p < 0.0001, IL6: p = 0.0017). d The commonly used senescence/SASP gene set (R-HSA-2559582) failed to predict the aging process in either human cohort. Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested; e The SenMayo gene set includes growth factors, transmembrane receptors, and cytokines/chemokines that are highly influenced by other members of the gene set. The circle size depicts groupwise interactions, arrows point the direction of these interactions. f SenMayo encodes a dense network of nine different protein classes within a strong interaction network. The size of each circle represents the connectivity with other members of the gene set, grey lines represent interactions92; g Genes included in the SenMayo gene set were significantly enriched with aging in both human cohorts. Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested Cohort A: n = 38 (19 young, 19 old, all ♀), Cohort B: n = 30 (15 young, 15 old, all ♀). **p < 0.01, ****p < 0.0001. Fig. 1a was designed using Biorender.com. Depicted are mean ± SEM. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 The SenMayo gene set predicts aging across tissues and species. a Compared to the conventional gene set, the SenMayo list is significantly enriched during the aging process in murine brain microglia (p = 0.1565 vs. p = 0.0052; GSE145265), n = 4 (2 young, 2 aged, all ♂), b murine prefrontal cortex (p = 0.1169 vs. p = 0.0013; GSE128770), n = 48 (24 young, 24 aged, all ♂), and (c) murine dorsal hippocampus (p = 0.1916 vs. p < 0.001; GSE94832), n = 12 (6 young (3 ♀), 6 aged (2♀). Likewise, the murine bone marrow (d) within the tabula muris senis (GSE149590102) has a higher enrichment of the SenMayo genes within the old cohort (p = 0.6043 vs. p = 0.0362), n = 11 (4 young (2 ♂, 2 ♀), 7 old (7 ♂, 0 ♀). Nominal p values were calculated as two-sided t-test, no adjustment since only one gene set was tested. Source data are provided as a Source Data file.
Fig. 2 The SenMayo gene set predicts aging across tissues and species. a Compared to the conventional gene set, the SenMayo list is significantly enriched during the aging process in murine brain microglia (p = 0.1565 vs. p = 0.0052; GSE145265), n = 4 (2 young, 2 aged, all ♂), b murine prefrontal cortex (p = 0.1169 vs. p = 0.0013; GSE128770), n = 48 (24 young, 24 aged, all ♂), and (c) murine dorsal hippocampus (p = 0.1916 vs. p < 0.001; GSE94832), n = 12 (6 young (3 ♀), 6 aged (2♀). Likewise, the murine bone marrow (d) within the tabula muris senis (GSE149590102) has a higher enrichment of the SenMayo genes within the old cohort (p = 0.6043 vs. p = 0.0362), n = 11 (4 young (2 ♂, 2 ♀), 7 old (7 ♂, 0 ♀). Nominal p values were calculated as two-sided t-test, no adjustment since only one gene set was tested. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 The SenMayo gene set tracks genetic and pharmacologic clearance of senescent cells. a The SenMayo panel successfully indicated aging in bone in mice (p value = 0.0023), n = 25 (12 young, 13 old (all ♀). Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested; b The elimination of p16Ink4a-expressing senescent cells by AP20187 administration was shown previously to reverse the aging bone phenotype37. The SenMayo gene set successfully demonstrated the significant reversal of the aging phenotype at the gene expression level upon the elimination of p16Ink4a-expressing senescent cells (p = 0.0054), n = 29 (13 Veh, 16 AP (all ♀). Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested; c By specifically using the expression patterns of the SenMayo gene set, our bone RNA-seq revealed no similarities in gene expression patterns between young (blue) and old + veh (red) treated mice, and a substantial overlap of expression profiles of old + AP (green) mice with young mice. The highlighted genes represent variables, and the arrows drawn from the origin indicate their “weight” in different directions, according to the theories of Gabriel103; d We used a previously published mRNA-seq dataset from human adipose tissue of our group24, 39, to evaluate changes in SenMayo following D + Q treatment. Adipose tissue was collected before and 11 days after three days of oral D + Q treatment. Figure was designed using Biorender.com; e Using SenMayo, there was a reduction of SenMayo (p = 0.002) in the subcutaneous fat samples in the subjects treated with D + Q, consistent with a reduction in senescent cell burden following D + Q treatment (n = 9 (7 ♂, 2 ♀)). Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested. Source data are provided as a Source Data file.
Fig. 3 The SenMayo gene set tracks genetic and pharmacologic clearance of senescent cells. a The SenMayo panel successfully indicated aging in bone in mice (p value = 0.0023), n = 25 (12 young, 13 old (all ♀). Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested; b The elimination of p16Ink4a-expressing senescent cells by AP20187 administration was shown previously to reverse the aging bone phenotype37. The SenMayo gene set successfully demonstrated the significant reversal of the aging phenotype at the gene expression level upon the elimination of p16Ink4a-expressing senescent cells (p = 0.0054), n = 29 (13 Veh, 16 AP (all ♀). Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested; c By specifically using the expression patterns of the SenMayo gene set, our bone RNA-seq revealed no similarities in gene expression patterns between young (blue) and old + veh (red) treated mice, and a substantial overlap of expression profiles of old + AP (green) mice with young mice. The highlighted genes represent variables, and the arrows drawn from the origin indicate their “weight” in different directions, according to the theories of Gabriel103; d We used a previously published mRNA-seq dataset from human adipose tissue of our group24, 39, to evaluate changes in SenMayo following D + Q treatment. Adipose tissue was collected before and 11 days after three days of oral D + Q treatment. Figure was designed using Biorender.com; e Using SenMayo, there was a reduction of SenMayo (p = 0.002) in the subcutaneous fat samples in the subjects treated with D + Q, consistent with a reduction in senescent cell burden following D + Q treatment (n = 9 (7 ♂, 2 ♀)). Nominal p value, calculated as two-sided t-test, no adjustment since only one gene set was tested. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 SASP-associated hematopoietic cells in human bone marrow are mainly of monocytic origin and communicate via the MIF pathway. a Using a previously published scRNA-seq dataset from human bone marrow (GSE12044648, n = 68,478 cells), we performed GSEA at the single cell level to uncover cells responsible for senescence/SASP-associated gene expression. The highest enrichment score (ES) for the SenMayo gene set (purple) occurred within the CD14+ and CD16+ monocytic cell cluster, represented in a Uniform Manifold Approximation and Projection (UMAP). We selected the top 10% of senescence/SASP-expressing cells to form the “SASP cells” (n = 6850 cells) cluster displaying an (b) independent enrichment of canonical senescence genes including CDKN1A/p21CIP1 and TGFB1 and which was likewise enriched for two aging signatures (GenAge: genes associated with aging in model organisms;49 and CellAge: positively regulated genes associated with aging in human cells (SASP cells are marked purple). T-test with adjustment for multiple testing according to the hurdle model from MAST package (CDKN1A: p < 0.0001; TGFB1: p < 0.0001). c The SASP cells showed the highest interaction strength with T cells in the bone marrow, the numbers represent the relative interaction strength as sum of interaction weights. Edge weights are proportional to interaction strength, and a thicker line refers to a stronger signal 52; d Among the interaction targets of SASP cells, T cells were predominantly targeted via the MHC-I, MIF, and PECAM1 pathways; e Members of the MIF and PECAM1 signaling pathways showed high expression patterns within the SASP population; f SASP cells were characterized by distinct co-expression patterns predicting functional clusters (e.g., JUN and CDKN2A), potentially overcoming difficulties of low expression of specific senescence-associated genes such as CDKN2A/P16ink4A. These strong indicators of co-expression were mathematically isolated by z-scores (Spearman correlation) (g) and spatially summarized (h) in sub-cell populations within the SASP cluster, as indicated by kernel gene-weighted density estimation in a t-distributed Stochastic Neighbor Embedding (tSNE) representation (EREG–IL1B: p < 0.0001, ICAM1–CDKN1A: p < 0.0001, JUN–CDKN2A: p < 0.0001). ****p < 0.0001, n = 22 (10 ♂, 12 ♀). The error bands show a confidence interval level of 0.95. Boxplot minimum is the smallest value within 1.5 times interquartile range below 25th percentile, maximum is the largest value within 1.5 times interquartile range above 75th percentile. Centre is the 50th percentile (median), box bounds 25th and 75th percentile. Source data are provided as a Source Data file.
Fig. 4 SASP-associated hematopoietic cells in human bone marrow are mainly of monocytic origin and communicate via the MIF pathway. a Using a previously published scRNA-seq dataset from human bone marrow (GSE12044648, n = 68,478 cells), we performed GSEA at the single cell level to uncover cells responsible for senescence/SASP-associated gene expression. The highest enrichment score (ES) for the SenMayo gene set (purple) occurred within the CD14+ and CD16+ monocytic cell cluster, represented in a Uniform Manifold Approximation and Projection (UMAP). We selected the top 10% of senescence/SASP-expressing cells to form the “SASP cells” (n = 6850 cells) cluster displaying an (b) independent enrichment of canonical senescence genes including CDKN1A/p21CIP1 and TGFB1 and which was likewise enriched for two aging signatures (GenAge: genes associated with aging in model organisms;49 and CellAge: positively regulated genes associated with aging in human cells (SASP cells are marked purple). T-test with adjustment for multiple testing according to the hurdle model from MAST package (CDKN1A: p < 0.0001; TGFB1: p < 0.0001). c The SASP cells showed the highest interaction strength with T cells in the bone marrow, the numbers represent the relative interaction strength as sum of interaction weights. Edge weights are proportional to interaction strength, and a thicker line refers to a stronger signal 52; d Among the interaction targets of SASP cells, T cells were predominantly targeted via the MHC-I, MIF, and PECAM1 pathways; e Members of the MIF and PECAM1 signaling pathways showed high expression patterns within the SASP population; f SASP cells were characterized by distinct co-expression patterns predicting functional clusters (e.g., JUN and CDKN2A), potentially overcoming difficulties of low expression of specific senescence-associated genes such as CDKN2A/P16ink4A. These strong indicators of co-expression were mathematically isolated by z-scores (Spearman correlation) (g) and spatially summarized (h) in sub-cell populations within the SASP cluster, as indicated by kernel gene-weighted density estimation in a t-distributed Stochastic Neighbor Embedding (tSNE) representation (EREG–IL1B: p < 0.0001, ICAM1–CDKN1A: p < 0.0001, JUN–CDKN2A: p < 0.0001). ****p < 0.0001, n = 22 (10 ♂, 12 ♀). The error bands show a confidence interval level of 0.95. Boxplot minimum is the smallest value within 1.5 times interquartile range below 25th percentile, maximum is the largest value within 1.5 times interquartile range above 75th percentile. Centre is the 50th percentile (median), box bounds 25th and 75th percentile. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 In murine bone and bone marrow mesenchymal cells, osteolineage cells constitute the largest proportion of SASP cells and communicate with osteolineage and chondrocytic cells via the MIF and PECAM1 pathways and show characteristics of terminal differentiation. a We analyzed a publicly available murine bone and bone marrow gene set (GSE12842354), and enriched 35,368 cells for the SenMayo gene set; b The top 10% senescence/SASP gene-expressing cells (n = 3537) were assigned to the “SASP cells” cluster. They displayed an increase in canonical markers of senescence including Cdkn1a/p21Cip1 and Tgfb1, and were enriched in the GenAge and CellAge gene sets (GenAge, CellAge49); T-test with adjustment for multiple testing according to the hurdle model from MAST package (Cdkn1a: p < 0.0001, Tgfb1: p < 0.0001). c The strongest interaction of the SASP cells was narrowed down to chondrocytic cells, while the osteolineage cells were another important crosstalk neighbor, the numbers represent the relative interaction strength as sum of interaction weights. Edge weights are proportional to interaction strength, and a thicker line refers to a stronger signal52. Two-sided unpaired t-test except for CCL2 in Cohort A: Kolmogorov–Smirnov test. d Outgoing interaction patterns of SASP cells (pink, left bottom quarter) indicated the importance of several signaling pathways that resulted in a significant enrichment of Mk, Angptl, Mif and Pecam1; (e) In pseudotime, the SASP cluster was most abundant in the terminal branches, and overexpressed Cdkn1a/p21Cip1 in terminal states (top-left inlay: the solid line represents the expression values as a function of pseudotime-progress, bottom red color on the left, terminal branch); f In their terminal differentiation, the SASP cluster was enriched in several factors, out of which distinct co-expressional patterns were extracted (Spearman correlation); g While the terminal differentiation was marked by a simultaneous loss of Pappa and Fgf7 (cluster 1, green in f), a significant correlation of Dkk1 with Cdkn2a/p16Ink41, likewise Bmp2 and Cdkn1a/p21Cip1, was mathematically predicted (cluster 2, pink in f). Fgf7–Pappa: p < 0.0001, Dkk1–Cdkn2a: p < 0.0001, Bmp2–Cdkn1a: p < 0.0001. ****p < 0.0001, n = 8 (4 bone, 4 bone marrow, all male). Depicted are mean ± SEM. The error bands show a confidence interval level of 0.95. Boxplot minimum is the smallest value within 1.5 times interquartile range below 25th percentile, maximum is the largest value within 1.5 times interquartile range above 75th percentile. Centre is the 50th percentile (median), box bounds 25th and 75th percentile. Source data are provided as a Source Data file.
Fig. 5 In murine bone and bone marrow mesenchymal cells, osteolineage cells constitute the largest proportion of SASP cells and communicate with osteolineage and chondrocytic cells via the MIF and PECAM1 pathways and show characteristics of terminal differentiation. a We analyzed a publicly available murine bone and bone marrow gene set (GSE12842354), and enriched 35,368 cells for the SenMayo gene set; b The top 10% senescence/SASP gene-expressing cells (n = 3537) were assigned to the “SASP cells” cluster. They displayed an increase in canonical markers of senescence including Cdkn1a/p21Cip1 and Tgfb1, and were enriched in the GenAge and CellAge gene sets (GenAge, CellAge49); T-test with adjustment for multiple testing according to the hurdle model from MAST package (Cdkn1a: p < 0.0001, Tgfb1: p < 0.0001). c The strongest interaction of the SASP cells was narrowed down to chondrocytic cells, while the osteolineage cells were another important crosstalk neighbor, the numbers represent the relative interaction strength as sum of interaction weights. Edge weights are proportional to interaction strength, and a thicker line refers to a stronger signal52. Two-sided unpaired t-test except for CCL2 in Cohort A: Kolmogorov–Smirnov test. d Outgoing interaction patterns of SASP cells (pink, left bottom quarter) indicated the importance of several signaling pathways that resulted in a significant enrichment of Mk, Angptl, Mif and Pecam1; (e) In pseudotime, the SASP cluster was most abundant in the terminal branches, and overexpressed Cdkn1a/p21Cip1 in terminal states (top-left inlay: the solid line represents the expression values as a function of pseudotime-progress, bottom red color on the left, terminal branch); f In their terminal differentiation, the SASP cluster was enriched in several factors, out of which distinct co-expressional patterns were extracted (Spearman correlation); g While the terminal differentiation was marked by a simultaneous loss of Pappa and Fgf7 (cluster 1, green in f), a significant correlation of Dkk1 with Cdkn2a/p16Ink41, likewise Bmp2 and Cdkn1a/p21Cip1, was mathematically predicted (cluster 2, pink in f). Fgf7–Pappa: p < 0.0001, Dkk1–Cdkn2a: p < 0.0001, Bmp2–Cdkn1a: p < 0.0001. ****p < 0.0001, n = 8 (4 bone, 4 bone marrow, all male). Depicted are mean ± SEM. The error bands show a confidence interval level of 0.95. Boxplot minimum is the smallest value within 1.5 times interquartile range below 25th percentile, maximum is the largest value within 1.5 times interquartile range above 75th percentile. Centre is the 50th percentile (median), box bounds 25th and 75th percentile. Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 The in silico predicted importance of the Mif pathway is reflected in the aged INK-ATTAC mouse model. a We compared young (n = 12) and old vehicle-treated mice (n = 13), and old mice treated with AP (n = 16). a Upregulation of Mif was confirmed by RT-qPCR (n = 24 young (12 Veh, 12 old (all female), p = 0.0102)); b The clearance of senescent cells in the aged cohort by AP treatment reduced this Mif expression (n = 26 old [12 Veh, 14 AP, all female], p = 0.0459). *p < 0.05. Two-sided unpaired t-tests. Source data are provided as a Source Data file.
Fig. 6 The in silico predicted importance of the Mif pathway is reflected in the aged INK-ATTAC mouse model. a We compared young (n = 12) and old vehicle-treated mice (n = 13), and old mice treated with AP (n = 16). a Upregulation of Mif was confirmed by RT-qPCR (n = 24 young (12 Veh, 12 old (all female), p = 0.0102)); b The clearance of senescent cells in the aged cohort by AP treatment reduced this Mif expression (n = 26 old [12 Veh, 14 AP, all female], p = 0.0459). *p < 0.05. Two-sided unpaired t-tests. Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 2 Not valid · 3 Not checked · 71 Own results and interpretations

54 more claims · 4 with their cited sources checked

Create a free account to see all 93 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 18
  • It may state two separate claims as one. 20
  • Borderline: one of the tests for a substantial claim is unclear. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

12 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 103 references

Cited by

See all 1,069

Metadata

Authors
Saul, D., Kosinsky, R. L., Atkinson, E. J., Doolittle, M. L., Zhang, X., LeBrasseur, N. K., Pignolo, R. J., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., Jurk, D., Passos, J. F., Hickson, L. J., Xue, A., Monroe, D. G., Tchkonia, T., Kirkland, J. L., Farr, J. N., & Khosla, S.
Affiliations
  • Mayo Clinic (US)
  • University of Minnesota (US)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
  • Saul, Dominik
  • Farr, Joshua N.
  • Khosla, Sundeep
Venue
Nature Communications
Published
2022-08-16
Volume
13
Issue
1
Pages
4827-4827
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4292004337
Cited by
1,022
References
104
Citations by year
2026: 336 · 2025: 341 · 2024: 219 · 2023: 115 · 2022: 11
FWCI
68.16
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
Funders
  • Dr. Mildred Scheel Stiftung für Krebsforschung
  • Foundation for the National Institutes of Health (R37 AG 013925, R33AG 61456, AG 013925, AG065868, AR070241)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
cellular senescence, senescence-associated secretory phenotype, senolytics, senescent cell clearance, bone marrow, bone, adipose tissue, hematopoietic cells, mesenchymal cells, single-cell transcriptomics, aging
MeSH terms
Adipose Tissue, Aged, Aging, Animals, Bone and Bones, Humans, Cellular Senescence, Mice, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. https://app.cochat.ai/papers/10.1038/s41467-022-32552-1
The paper
Saul, D., Kosinsky, R. L., Atkinson, E. J., Doolittle, M. L., Zhang, X., LeBrasseur, N. K., Pignolo, R. J., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., Jurk, D., Passos, J. F., Hickson, L. J., Xue, A., Monroe, D. G., Tchkonia, T., Kirkland, J. L., Farr, J. N., & Khosla, S. (2022). A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nature Communications. https://doi.org/10.1038/s41467-022-32552-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.